Tier 4 — mechanistic

Corrigendum to: 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex

Aging cell 2022 21; 11; e13672

Bibliography

PubMed
PMID 35895871
PubMed Central
PMC9649595
DOI
10.1111/acel.13672
Funding
Correction notice; funding information belongs to the original study.
Competing interests
Correction notice; consult the original study’s disclosures.

Study snapshot

DesignPublished correction or corrigendum
ModelPublication correction
SampleNo new animals
InterventionCorrection to the mouse-lifespan report PMID 33788371
DurationPublished correction
EndpointsCorrection of the linked original publication

What the study showed, in plain terms

The notice added an omitted author and affiliation to the original mouse-lifespan publication.

Key findings

The notice added an omitted author and affiliation to the original mouse-lifespan publication.

What this study can and cannot tell us

Authorship correction, not a new longevity experiment.

Related papers in the corpus

Tier 3
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
Harrison DE et al. · Aging cell · 2021
Tier 3
NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang H et al. · Science (New York, N.Y.) · 2016
Tier 4
Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial
McDermott MM et al. · Nature communications · 2024
Tier 4
Corrigendum to "Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm"
et al. · International journal of toxicology · 2022
Tier 4
Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD + levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Dellinger RW et al. · NPJ aging and mechanisms of disease · 2018

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology